• Homepage
Polish Wersja polska
  • Our offer
  • Science
  • News & events
  • Careers
  • About us
  • Contact
Selvita
Header
  • Innovative compounds
    • Current pipeline
    • Oncology - SEL24
    • CNS - SEL103
  • Drug discovery
    • Target identification and modeling
    • Selvita Protein Modeling Platform
    • Virtual screening
    • Focused library design
    • Lead optimization
    • In silico compound profiling
  • Chemical development services
    • Synthesis design
    • Custom synthesis and drug form development
    • Software for synthesis optimization
  • IT for research
    • Laboratory information management systems
  • Biology services
Selvita is a product and solution provider for the pharmaceutical and biotechnology industry. We deliver comprehensive solutions to the customers from pharma & biotech industry targeted at lowering the cost of introducing innovative therapeutical compounds to the market...
News
  • Selvita and Orion Pharma will collaborate on SEL103 - Alzheimer's disease program
  • Selvita participates in the ChemOutsourcing Conference and Exhibition
  • Selvita has released the most recent results of its SEL24 oncology program
  • Selvita participates in the BioPh Europe conference
  • Selvita signs a drug discovery services contract with Rottapharm Madaus
SEL24 - an innovative anti-cancer compound
Synthesis services
Synthesis services
SEL24 - an innovative anti-cancer compound
Copyright © 2008 Selvita Sp. z o.o.
  • Our offer
  • Science
  • News & events
  • Careers
  • About us
  • Contact